|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/425 | |
| A61K 47/12 | |||
| A61K 47/02 | |||
| A61P 35/00 | |||
| A61K 31/427 | |||
| A61K 47/44 | |||
| A61K 9/00 |
| (11) | Number of the document | 1938821 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08152923.2 |
| Date of filing the European patent application | 2002-01-22 | |
| (97) | Date of publication of the European application | 2008-07-02 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-30 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 264228 P | 2001-01-25 | US | |
| 290008 P | 2001-05-11 | US |
| (72) |
Bandyopadhyay, Rebanta, US
Malloy, Timothy M., US
Panaggio, Andrea, US
Raghavan, Krishnaswamy Srinivas, US
Varia, Sailesh Amilal, US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | Dosage forms of an epothilone analogue for the treatment of cancer |
| Dosage forms of an epothilone analogue for the treatment of cancer |